Latest filing published 16 Sept 2025 for Alligator Bioscience AB, €2,857.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Johan Giléus: trading record in brief
All filings by Johan Giléus on record concern Alligator Bioscience AB, in the capacity of finance chief. The record holds 9 filings, for trades running from 17 February 2025 to 19 March 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 19 March 2026, reports a transaction in Alligator Bioscience AB. Filings reach the Finansinspektionen feed a median of 1 day after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Johan Giléus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ €0.28570.14% mcap100.0% of flowAktieISIN SE0024173637FI:A003S326-1
- 20,000 shares@ €0.33780.33% mcap100.0% of flowAktieISIN SE0024173637FI:A003O552-1
2 of 2 declarations